In a new study, doctors from the University of Illinois at Chicago found that Chinese patients die from a range of diseases faster than US patients, and that many Chinese doctors may be misdiagnosing patients and treating them with ineffective and often dangerous drugs.
The study, published in the American Journal of Medicine, used data from the National Center for Complementary and Alternative Medicine (NCCAM), a federal research agency, to track the death rates of 1,096 Chinese patients from 2013 to 2016.
Of those, the researchers found that about a third of those who died were over the age of 60.
The researchers also found that nearly half of those patients died from lung cancer, kidney failure, diabetes and certain forms of heart disease.
The US rate of death is more than double the Chinese rate.
“These are not just Chinese people,” said Dr. Yung-Hui Li, a physician at the NCCAM who was not involved in the study.
“They are very young Chinese, middle-aged Chinese, older Chinese, and people who have a history of chronic diseases.”
The study also found a striking disparity between the Chinese and the US death rates.
Chinese patients were nearly four times more likely to die of pneumonia than US people, and nearly five times more than their counterparts in Germany.
But the researchers did not say why this was the case.
In contrast, a recent study in the journal Lancet, using data from CDC, found that in the US, fewer than 10% of deaths were due to COVID-19.
Dr. Li, who also was not a co-author on the study, said that in China, many people who contract pneumonia don’t know that they have it, and often don’t seek treatment.
“In China, if someone gets pneumonia, they don’t tell their friends, they’re too embarrassed,” he said.
“The culture is really, really bad, and you have this stigma that you have to be cured.”
Chinese patients often don�t get treatment for their pneumonia because it is a common complication of other illnesses, including chronic kidney disease, diabetes, and heart disease, according to Dr. Wang Dong, a research professor at the University and chair of the Department of Emergency Medicine at the National Health and Medical Research Council of China.
Chinese doctors sometimes treat these conditions with expensive and sometimes dangerous drugs, and even then they may not be able to reverse the effects of the drugs.
In addition, many doctors in China don�s health care system don� t have proper education, training, or experience, and they often fail to recognize that people who get pneumonia don�T necessarily need treatment, according a report from the NHCAM.
Many doctors also aren�t aware of the fact that they are in charge of care for patients who do not have a diagnosis or a treatment plan.
The Chinese government has been slow to act on COVIDs in China.
The country has spent $8 billion on research and clinical trials on the virus and other diseases in recent years, and has a large number of public health laboratories that work to help patients with COVID, including the National Institutes of Health (NIH).
In December, the Chinese government approved a $7.5 billion COVID vaccine that will go into clinical trials this year, but the government has not yet given the government the funding it needs to implement the vaccine.
In December 2016, China began sending the first vaccines to hospitals, where they will be tested for the virus, and the government also announced it will pay for a study to compare the vaccine to other vaccines and determine if the vaccine is safe.
But many Chinese health care workers don�ll be able access the vaccine due to strict health and safety regulations.
The NCCAMS said it has a team of researchers working to implement a program to distribute the vaccine at hospitals.
In the meantime, Dr. Wei Wang, an emergency physician at Beijing’s Beijing Medical University, said he was hesitant to try out the vaccine on Chinese patients because of concerns about safety.
“I am worried about it being so difficult for the Chinese doctors, and especially the older doctors, to understand,” he told Medical News Day.
“This is something that has not been tested on other populations, but for the older people, we have to keep the public calm.”